{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:44Z","timestamp":1786119644493,"version":"build-2736575974"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/aog.0b013e318162f690","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:40:23Z","timestamp":1291102823000},"page":"436-447","source":"Crossref","is-referenced-by-count":167,"title":["Endometrial Cancer"],"prefix":"10.1097","volume":"111","author":[{"given":"Joel I.","family":"Sorosky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer Statistics 2007.","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R2-27-20210126","first-page":"413","article-title":"ACOG Practice Bulletin No. 65. American College of Obstetricians and Gynecologists.","volume":"106","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R3-27-20210126","first-page":"47","article-title":"Carcinoma of the corpus uteri.","volume":"6","author":"Creasman","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"R4-27-20210126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2005.01.007","article-title":"Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors.","volume":"97","author":"Courneya","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R5-27-20210126","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0002-9378(96)70659-2","article-title":"Obesity and prognosis in endometrial cancer.","volume":"174","author":"Anderson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R6-27-20210126","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"R7-27-20210126","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/cncr.22351","article-title":"Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study.","volume":"107","author":"von Gruenigen","year":"2006","journal-title":"Cancer"},{"key":"R8-27-20210126","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9378(11)91709-8","article-title":"Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study.","volume":"167","author":"Brinton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R9-27-20210126","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R10-27-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9378(95)90125-6","article-title":"Primary prevention of gynecologic cancers.","volume":"172","author":"Grimes","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R11-27-20210126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<111::AID-JSO5>3.0.CO;2-F","article-title":"The National Cancer Data Base report on endometrial cancer.","volume":"61","author":"Partridge","year":"1996","journal-title":"J Surg Oncol"},{"key":"R12-27-20210126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/gyno.1995.1024","article-title":"Racial differences in tumor grade among women with endometrial cancer.","volume":"56","author":"Hill","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R13-27-20210126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.","volume":"11","author":"Magriples","year":"1993","journal-title":"J Clin Oncol"},{"key":"R14-27-20210126","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2005.10.026","article-title":"Comparison of uterine malignancies that develop during and following tamoxifen therapy.","volume":"101","author":"Ferguson","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R15-27-20210126","first-page":"265","article-title":"Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.","volume":"81","author":"Brinton","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R16-27-20210126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia: a long-term study of \u201cuntreated\u201d hyperplasia in 170 patients.","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"R17-27-20210126","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"R18-27-20210126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"R19-27-20210126","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system.","volume":"188","author":"Wildemeersch","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R20-27-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2003.08.007","article-title":"Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and\/or complex hyperplasia with atypia.","volume":"91","author":"Lowe","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R21-27-20210126","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/cncr.21058","article-title":"The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system.","volume":"103","author":"Baak","year":"2005","journal-title":"Cancer"},{"key":"R22-27-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31802e4696","article-title":"Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.","volume":"26","author":"Mutter","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R23-27-20210126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.AOG.0000152350.10875.02","article-title":"Dysplasia associated with atypical glandular cells on cervical cytology.","volume":"105","author":"Sharpless","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R24-27-20210126","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.AOG.0000202401.29145.68","article-title":"Clinical significance of atypical glandular cells on cervical cytology.","volume":"107","author":"Schnatz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R25-27-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(92)90246-F","article-title":"Positive peritoneal cytology is an adverse factor in endometrial cancer only if there is other evidence of extrauterine disease.","volume":"46","author":"Kadar","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R26-27-20210126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer.","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R27-27-20210126","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199712183372502","article-title":"Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen\/Progestin Interventions Trial.","volume":"337","author":"Langer","year":"1997","journal-title":"N Engl J Med"},{"key":"R28-27-20210126","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/mob.2000.103092","article-title":"Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: is it always necessary to perform an endometrial biopsy?","volume":"182","author":"Gull","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R29-27-20210126","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.280.17.1510","article-title":"Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities.","volume":"280","author":"Smith-Bindman","year":"1998","journal-title":"JAMA"},{"key":"R30-27-20210126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-7844(97)00286-X","article-title":"Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome.","volume":"90","author":"Sood","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R31-27-20210126","first-page":"692","article-title":"Computed tomography in endometrial carcinoma.","volume":"95","author":"Connor","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R32-27-20210126","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2006.10.007","article-title":"Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma.","volume":"104","author":"Chung","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R33-27-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2005.12.028","article-title":"MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion.","volume":"102","author":"Nakao","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R34-27-20210126","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2004.08.009","article-title":"Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.","volume":"95","author":"Horowitz","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R35-27-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: survival comparisons with and without pelvic lymph node sampling.","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R36-27-20210126","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.","volume":"23","author":"Cragun","year":"2005","journal-title":"J Clin Oncol"},{"key":"R37-27-20210126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R38-27-20210126","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"R39-27-20210126","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ijgc-00009577-200403000-00022","article-title":"Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study.","volume":"14","author":"Homesley","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R40-27-20210126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2006.10.013","article-title":"Endometrial cancer\u2013revisiting the importance of pelvic and para aortic lymph nodes.","volume":"104","author":"Aalders","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R41-27-20210126","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.AOG.0000149151.74863.c4","article-title":"Surgical staging for patients presenting with grade 1 endometrial carcinoma.","volume":"105","author":"Ben-Shachar","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R42-27-20210126","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2004.11.030","article-title":"Endometrial cancer: can nodal status be predicted with curettage?","volume":"96","author":"Mariani","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R43-27-20210126","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2005.07.014","article-title":"Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.","volume":"99","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R44-27-20210126","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study [published erratum appears in Gynecol Oncol 2004;94:241\u20132].","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R45-27-20210126","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with Stage I endometrial carcinoma: multicentre randomised trial. PORTEC Study Group Post Operative Radiation Therapy in Endometrial Carcinoma.","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"R46-27-20210126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.11.003","article-title":"The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005.","volume":"105","author":"Naumann","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R47-27-20210126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2006.11.007","article-title":"Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches.","volume":"105","author":"Barakat","year":"2007","journal-title":"Gyncol Oncol"},{"key":"R48-27-20210126","first-page":"793","article-title":"Second primary cancers after sporadic and familial colorectal cancer.","volume":"10","author":"Hemminki","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R49-27-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"R50-27-20210126","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2005.06.009","article-title":"BRCA2 germline mutation in a woman with uterine serous papillary carcinoma: a case report.","volume":"99","author":"Lavie","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R51-27-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R52-27-20210126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/gyno.1999.5568","article-title":"Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.","volume":"75","author":"Hornreich","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R53-27-20210126","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2000.18.20.3459","article-title":"Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.","volume":"18","author":"Barakat","year":"2000","journal-title":"J Clin Oncol"},{"key":"R54-27-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme.","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R55-27-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(92)90134-5","article-title":"Detection and patterns of treatment failure in 300 consecutive cases of \u201cearly\u201d endometrial cancer after primary surgery.","volume":"47","author":"Podczaski","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R56-27-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial.","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R57-27-20210126","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1525-1438.2007.00858.x","article-title":"Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.","volume":"17","author":"Huh","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R58-27-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2003.09.018","article-title":"Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.","volume":"92","author":"Whitney","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R59-27-20210126","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.","volume":"22","author":"Fleming","year":"2004","journal-title":"J Clin Oncol"},{"key":"R60-27-20210126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/gyno.2001.6445","article-title":"Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.","volume":"83","author":"Geisler","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R61-27-20210126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0015-0282(01)02937-5","article-title":"Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.","volume":"77","author":"Lowe","year":"2002","journal-title":"Fertil Steril"},{"key":"R62-27-20210126","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter Phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"R63-27-20210126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200802000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:44:07Z","timestamp":1786041847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200802000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e318162f690","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}